JYNT
JOINT Corp
$8.95
-0.10 (-1.10%)
At close · Jul 7
Market Cap
$127.59M
Shares
14,255,396
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$54.9M
+5.2%
FY2025
Net Income
$2.91M
+150.2%
FY2025
Gross Margin
79.55%
+1.6pp
FY2025
Operating Margin
-1.66%
+2pp
FY2025
Diluted EPS
$0.19
+150%
FY2025
Operating Cash Flow
$1.84M
-80.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $56.64M | $54.9M | $52.16M | $117.7M | $101.25M | $80.01M | $58.68M | $48.45M | $36.66M | $24.92M | $20.52M | $13.84M | $7.12M | $5.96M | |
| $10.98M | $11.23M | $11.52M | $10.48M | $11.52M | $7.67M | $6.51M | $5.57M | $4.31M | $3.22M | $2.94M | $2.82M | $2.35M | $2.01M | |
| $45.66M | $43.67M | $40.65M | $107.22M | $89.74M | $72.35M | $52.18M | $42.88M | $32.35M | $21.69M | $17.58M | $11.02M | $4.77M | $3.95M | |
| — | 79.55% | 77.92% | 91.1% | 88.63% | 90.42% | 88.91% | 88.51% | 88.24% | 87.06% | 85.68% | 79.62% | 67.04% | 66.33% | |
| $13.51M | $13.3M | $10.97M | $8.69M | $10.97M | $11.42M | $7.8M | $6.91M | $4.82M | $4.47M | $4.42M | $2.84M | $1.12M | $781.26K | |
| $29.8M | $29.63M | $30.12M | $26.23M | $30.12M | $50.85M | $36.2M | $30.54M | $25.24M | $18.12M | $22.09M | $16.22M | $5.07M | $2.66M | |
| $44.99M | $44.58M | $42.47M | $36.2M | $42.47M | $66.19M | $46.73M | $39.36M | $31.61M | $24.61M | $29.07M | $20.33M | $6.4M | $3.51M | |
| $1.74M | — | — | $3.43M | $2.5M | $1.51M | $1.45M | $1.05M | $506.3K | $578.88K | $747.73K | $476.16K | — | — | |
| $1.69M | $1.71M | $4.72M | $8.58M | $6.65M | $3.92M | $2.73M | $1.9M | $1.56M | $2.02M | $2.57M | $1.27M | $210.12K | $70.73K | |
| $638.83K | -$913.38K | -$1.89M | $318.3K | -$1.89M | $6.13M | $5.49M | $3.41M | $142.56K | -$3.33M | -$15.01M | -$9.32M | -$1.63M | $439.79K | |
| — | -1.66% | -3.62% | 0.27% | -1.87% | 7.66% | 9.36% | 7.05% | 0.39% | -13.37% | -73.13% | -67.34% | -22.86% | 7.38% | |
| $2.33M | $800.34K | $2.83M | $8.9M | $4.76M | $10.05M | $8.23M | $5.31M | $1.7M | -$1.31M | -$12.44M | -$8.05M | -$1.42M | $510.51K | |
| $738.19K | $683.87K | $280.29K | -$64.29K | -$133.1K | -$69.88K | -$79.48K | -$42.22K | -$33.59K | -$64.46K | $13.3K | $283.27K | -$64.08K | -$32K | |
| $1.38M | -$229.5K | -$1.61M | $254.01K | -$1.61M | $6.06M | $5.41M | $3.37M | $108.97K | -$3.4M | -$15.01M | -$9.03M | -$1.69M | $407.79K | |
| $36.36K | $38.65K | $5606 | $11.02M | $5606 | -$1.51M | -$7.75M | $48.71K | -$37.73K | $35.88K | $164.43K | -$235.86K | $1.34M | $252.15K | |
| $3.24M | $2.91M | -$5.8M | -$9.75M | $626.71K | $7.57M | $13.17M | $3.32M | $146.7K | -$3.43M | -$15.17M | -$8.8M | -$3.03M | $155.64K | |
| — | 5.3% | -11.11% | -8.29% | 0.62% | 9.46% | 22.44% | 6.86% | 0.4% | -13.77% | -73.93% | -63.59% | -42.59% | 2.61% | |
| $0 | — | — | — | — | — | $0 | $0 | $0 | — | — | — | — | — | |
| USD/shares | — | $0.19 | -$0.39 | -$0.66 | -$0.39 | $0.53 | $0.94 | $0.24 | $0.01 | -$0.26 | — | — | -$0.56 | $0.03 |
| USD/shares | — | $0.19 | -$0.38 | -$0.65 | -$0.38 | $0.51 | $0.90 | $0.23 | $0.01 | -$0.26 | — | — | -$0.56 | $0.02 |
| shares | — | 15.13M | 14.92M | 14.69M | 14.49M | 14.32M | 14M | 13.82M | 13.67M | 13.25M | 12.7M | 10.04M | 5.45M | 5.31M |
| shares | — | 15.19M | 15.15M | 14.94M | 14.87M | 14.94M | 14.58M | 14.47M | 14.03M | 13.25M | 12.7M | 10.04M | 5.45M | 6.67M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2013–FY2025: $12.41M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
38.91×
Medical Care Facilities median 16.79×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Franchise Operations | $54,895,592 | $52,163,430 | $46,977,477 | $41,830,016 | $35,662,779 | $26,925,769 | $22,643,316 | $17,116,000 |
| Corporate Clinics | — | — | — | $59,422,294 | $44,348,234 | $31,757,207 | $25,807,584 | $19,545,000 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Royalty | $33,203,885 | $32,144,796 | $29,160,832 | $26,190,531 | $22,062,989 | $15,886,051 | $13,557,170 | $10,141,036 |
| Advertising | $10,451,281 | $9,180,281 | $8,321,043 | $7,456,696 | $6,298,924 | $4,506,413 | $3,884,055 | $2,862,244 |
| Technology Service | $6,037,385 | $5,687,326 | $5,086,562 | $4,290,739 | $3,383,856 | $2,694,520 | $1,865,779 | $1,290,135 |
| Franchise | $3,371,504 | $2,997,850 | $2,882,895 | $2,441,325 | $2,659,097 | $2,100,800 | $1,791,545 | $1,688,039 |
| Product And Service Other | $1,831,537 | $2,153,177 | $1,526,145 | $2,153,177 | $1,257,913 | $861,181 | $740,918 | $535,560 |
| Regional Developer Fees | — | — | — | $0 | $0 | $876,804 | $803,849 | $599,370 |
| Revenues and Management Fees from Company Clinics | — | — | — | $59,422,294 | $44,348,234 | $31,757,207 | $25,807,584 | $19,545,276 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|
| Franchise Operations | $20,332,354 | $17,340,402 | $15,353,621 | $12,561,278 | $10,974,769 | $8,083,000 |
| Corporate Clinics | -$2,502,643 | $110,257 | $6,599,932 | $4,508,990 | $3,365,295 | $1,475,000 |
Operating Margin by Segment (%)
| Component | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|
| Franchise Operations | 43.3% | 41.5% | 43.1% | 46.7% | 48.5% | 47.2% |
| Corporate Clinics | — | 0.2% | 14.9% | 14.2% | 13% | 7.5% |